Showing results (1-10 of 298) with videos related to
Sort By:
Pageof 30
Expert Review of Endocrinology & Metabolism|August 6, 2026
Targeting kidney disease in type 1 diabetes: progress and promiseMarcel H A Muskiet, David Z I CherneyLancet (London, England)|November 9, 2025
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?Marcel H A Muskiet, Massimo Nardone, Patrick C N Rensen, et al.Kidney International Reports|May 28, 2026
Novel Therapeutic Strategies for Patients With CKD and Diabetes MellitusLuxcia Kugathasan, Alexandra Katz, Marcel H A Muskiet, et al.Diabetes, Obesity & Metabolism|January 27, 2026
Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trialMassimo Nardone, Erik Moedt, Hiddo J L Heerspink, et al.Nephrology News & Issues|May 4, 2013
Advances in the treatment of diabetic nephropathyDavid Z I CherneyNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2026
Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trialsMichaël J B van Baar, Petter Bjornstad, Daan J Touw, et al.Current Opinion in Nephrology and Hypertension|December 4, 2014
Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathyMarko Škrtić, David Z I CherneyClinical and Experimental Hypertension (New York, N.Y. : 1993)|October 30, 2013
Gender, clamped hyperglycemia and arterial stiffness in patients with uncomplicated type 1 diabetes mellitusDavid Z I Cherney, Alberto MontanariDiabetes Care|June 4, 2011
Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetesDavid Z I Cherney, Etienne B SochettKidney International|January 29, 2021
Therapeutic transformation for diabetic kidney diseaseKatherine R Tuttle, David Z I CherneyPageof 30